myristic acid has been researched along with Non-alcoholic Fatty Liver Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa Bazotte, R; Curi, R; Godoy, G; Masetto Antunes, M; Vergílio Visentainer, J | 1 |
| Chen, Y; Du, S; Feng, R; Li, C; Li, Y; Luo, C; Niu, Y; Okekunle, AP; Zi, T | 1 |
| Alarcón-Vila, C; Baulies, A; Caballeria, J; Casas, J; Elena, M; Fabriàs, G; Fernandez-Checa, JC; García-Ruiz, C; Martínez, L; Torres, S | 1 |
| Ebinuma, H; Hibi, T; Hokari, R; Irie, R; Miura, S; Saito, H; Suzuki, T; Teratani, T; Tomita, K; Yokoyama, H | 1 |
1 review(s) available for myristic acid and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
The Myristic Acid:Docosahexaenoic Acid Ratio Versus the n-6 Polyunsaturated Fatty Acid:n-3 Polyunsaturated Fatty Acid Ratio as Nonalcoholic Fatty Liver Disease Biomarkers.
Topics: Biomarkers; Docosahexaenoic Acids; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Humans; Inflammation; Myristic Acid; Non-alcoholic Fatty Liver Disease | 2022 |
3 other study(ies) available for myristic acid and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case - control study.
Topics: Adult; Body Mass Index; Case-Control Studies; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Female; gamma-Linolenic Acid; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Myristic Acid; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Thinness | 2017 |
Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
Topics: Animals; Anthracenes; Apoptosis; Ceramides; Cholesterol; Disease Models, Animal; Endoplasmic Reticulum Stress; Fatty Acids, Monounsaturated; Hepatocytes; JNK Mitogen-Activated Protein Kinases; Lipodystrophy; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Liver; Myristic Acid; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Oxidoreductases; Palmitic Acid; Protein Kinase Inhibitors; Reactive Oxygen Species; Ruthenium Red; Sphingosine N-Acyltransferase; Time Factors | 2015 |
Plasma free myristic acid proportion is a predictor of nonalcoholic steatohepatitis.
Topics: Adult; Biomarkers; Diagnosis, Differential; Fatty Acids, Nonesterified; Fatty Liver; Female; Humans; Male; Middle Aged; Myristic Acid; Non-alcoholic Fatty Liver Disease; Predictive Value of Tests; Regression Analysis; Retrospective Studies | 2011 |